Molecular analysis of a kinase essential for replication of Plasmodium falciparum
恶性疟原虫复制所必需的激酶的分子分析
基本信息
- 批准号:7868632
- 负责人:
- 金额:$ 13.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAffinityAge-YearsAntimalarialsBiochemicalBiologicalBiological ProcessBiologyBloodBostonCalciumCandidate Disease GeneCellsCessation of lifeChild MortalityClinicalCommitDataDevelopment PlansDrug Delivery SystemsDrug resistanceEnvironmentEnzymesEpitopesErythrocytesEvaluationFacultyFamilyFutureGenesGeneticGoalsHIVHumanHuman GenomeImmunoelectron MicroscopyImmunofluorescence ImmunologicIn VitroIncubatedInfectionKnock-outLife Cycle StagesMalariaMass Spectrum AnalysisMediatingMentorshipMolecularMolecular AnalysisMolecular BiologyPalmitic Acylation SiteParasitesParasitologyPathogenesisPathway interactionsPatternPediatric HospitalsPeptide HydrolasesPharmaceutical PreparationsPhosphorylationPhosphotransferasesPlantsPlasmodium falciparumPositioning AttributeProcessProteinsProteomicsPublic Health SchoolsRecombinantsRegulationReportingResearchResistanceResistance developmentRoleScanningSignal TransductionStagingSystemTechniquesTestingTextTherapeuticTimeTrainingTransgenic OrganismsTropical MedicineVaccinesWorkabstractingasexualbasecalcium-dependent protein kinasecareercareer developmentdesignenzyme activityexperiencegenetic manipulationin vivonovelpathogenpreferencepreventprogramsprotein transportresearch studytrafficking
项目摘要
DESCRIPTION (provided by applicant):
NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE.
==================
Malaria is the fourth leading cause of mortality for children under five years of age globally, with most of these deaths resulting from Plasmodium falciparum. A molecular understanding of the life cycle of P. falciparum will facilitate the rational design of new therapies. P. falciparum requires efficient invasion into and egress out of human erythrocytes during the asexual replication stage of the parasite life cycle. Our preliminary data have identified a plant-like calcium-dependent protein kinase PfCDPK5 that is crucial for P. falciparum egress. These experiments have generated the first functional knockout of an essential blood-stage gene in P. falciparum. PfCDPK5-deficient parasites arrest at a very late-stage of the intra-erythrocytic life cycle. We hypothesize that PfCDPK5 mediates a critical calcium-dependent signal required for P. falciparum egress. The goals of this proposal are to gain a better understanding of PfCDPK5 function and elucidate its role in parasite egress from infected erythrocytes. In the first aim, the candidate will determine the localization, trafficking, and regulation of this essential kinase. Using two mass spectrometry based techniques and a third candidate gene approach, the experiments of the second aim will identify the in vivo substrate(s) of PfCDPK5. These studies will be conducted under the mentorship of Dr. Dyann Wirth, a pioneer in P. falciparum genetics and mechanisms of drug resistance, and the co-mentorship of Dr. Manoj Duraisingh, an expert in P. falciparum genetic manipulation and molecular biology. In addition to the proposed experiments, the candidate's career development goals are to gain expertise in parasitology, P. falciparum molecular biology, and tropical medicine. These immediate goals will be achieved by attending formal courses in proteomics, parasite biology, and tropical medicine and by receiving mentorship and guidance from his scientific advisory committee. The candidate's long-term career goals are to attain a tenure-track faculty position and to continue his research on the molecular pathogenesis of malaria. The training opportunities at the Harvard School of Public Health together with the mentorship of Drs. Wirth and Duraisingh are an ideal environment for this career development program. Children's Hospital Boston is committed to this career development plan and has assured that the candidate will be able to devote at least 75% full-time effort to the activities described in this proposal. (Relevance): Malaria is the fourth leading cause of mortality for children under five years of age globally, with most of these deaths resulting from Plasmodium falciparum infection. The goal of this application is gain a better understanding of the molecular mechanisms of P. falciparum replication in human red blood cells. Using genetic and biochemical techniques, this project will characterize the key biological process of parasite egress from red blood cells and ultimately identify new targets for future anti- malarial medications.
描述(由申请人提供):
注意:此摘要是从应用程序中提取的,尚未由SRA证明。当应用程序扫描过程存在问题时,提取的文本可能不正确或不完整。
===================
疟疾是全球五岁以下儿童死亡率的第四个主要原因,其中大多数死亡造成了恶性疟原虫。对恶性疟原虫生命周期的分子理解将有助于新疗法的合理设计。恶性疟原虫需要在寄生虫生命周期的无性复制阶段中有效入侵并从人类红细胞中出口。我们的初步数据已经确定了一种类似植物的钙依赖性蛋白激酶PFCDPK5,该蛋白质激酶PFCDPK5对于恶性疟原虫出口至关重要。这些实验已经产生了恶性疟原虫中必需血液阶段基因的第一个功能敲除。 PFCDPK5缺乏的寄生虫在肉毒内生命周期的非常晚阶段停滞。我们假设PFCDPK5介导了恶性疟原虫出口所需的关键钙依赖性信号。该提案的目标是更好地了解PFCDPK5功能,并阐明其在感染红细胞中的寄生虫出口中的作用。在第一个目标中,候选人将确定这种基本激酶的本地化,贩运和调节。使用两种基于质谱的技术和第三个候选基因方法,第二个目标的实验将识别PFCDPK5的体内底物。这些研究将在恶性疟原虫遗传学和耐药性机制的先驱迪恩·沃思(Dyann Wirth)博士的指导下进行,也是恶性疟原虫遗传操纵和分子生物学专家Manoj Duraisingh博士的同事。除了提出的实验外,候选人的职业发展目标是获得寄生虫学,恶性疟原虫分子生物学和热带医学方面的专业知识。这些即时目标将通过参加蛋白质组学,寄生虫生物学和热带医学的正式课程,并获得其科学咨询委员会的指导和指导。候选人的长期职业目标是达到终身教师职位,并继续对疟疾分子发病机理进行研究。哈佛大学公共卫生学院的培训机会以及博士的指导。 Wirth和Duraisingh是该职业发展计划的理想环境。波士顿儿童医院致力于这项职业发展计划,并保证候选人将能够为本提案中描述的活动提供至少75%的全职努力。 (相关性):疟疾是全球五岁以下儿童死亡率的第四个主要原因,其中大多数死亡是由于恶性疟原虫感染而导致的。该应用的目的是更好地了解人类红细胞中恶性疟原虫复制的分子机制。使用遗传和生化技术,该项目将表征红细胞中寄生虫出口的关键生物学过程,并最终确定未来抗量药物的新靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY D DVORIN其他文献
JEFFREY D DVORIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY D DVORIN', 18)}}的其他基金
Functional characterization of striated fiber assemblins in malaria parasites
疟疾寄生虫中横纹纤维组装体的功能特征
- 批准号:
10675782 - 财政年份:2023
- 资助金额:
$ 13.23万 - 项目类别:
Functional investigation of a novel and essential subcellular compartment in Plasmodium falciparum transmission stage parasites
恶性疟原虫传播阶段寄生虫中新型重要亚细胞区室的功能研究
- 批准号:
10458816 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别:
Functional investigation of a novel and essential subcellular compartment in Plasmodium falciparum transmission stage parasites
恶性疟原虫传播阶段寄生虫中新型重要亚细胞区室的功能研究
- 批准号:
10584525 - 财政年份:2022
- 资助金额:
$ 13.23万 - 项目类别:
Molecular mechanisms of schizogony in malaria parasites
疟原虫分裂的分子机制
- 批准号:
10620476 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Molecular mechanisms of schizogony in malaria parasites
疟原虫分裂的分子机制
- 批准号:
10161727 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Molecular mechanisms of schizogony in malaria parasites
疟原虫分裂的分子机制
- 批准号:
10627871 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Molecular mechanisms of schizogony in malaria parasites
疟原虫分裂的分子机制
- 批准号:
9797203 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Molecular mechanisms of schizogony in malaria parasites
疟原虫分裂的分子机制
- 批准号:
10407023 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Essential gene discovery in the malaria parasite Plasmodium falciparum
疟原虫恶性疟原虫中重要基因的发现
- 批准号:
8564839 - 财政年份:2013
- 资助金额:
$ 13.23万 - 项目类别:
Molecular characterization and substrate identification of malaria kinase PfCDPK5
疟疾激酶 PfCDPK5 的分子表征和底物鉴定
- 批准号:
8525534 - 财政年份:2013
- 资助金额:
$ 13.23万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
FURTHER DEVELOPMENT OF COLOVAC, A MULTI-ANTIGEN MULTI-PEPTIDE VACCINE, FOR COLON CANCER PREVENTION
进一步开发用于预防结肠癌的多抗原多肽疫苗 COLOVAC
- 批准号:
10021897 - 财政年份:2019
- 资助金额:
$ 13.23万 - 项目类别:
Molecular analysis of a kinase essential for replication of Plasmodium falciparum
恶性疟原虫复制所必需的激酶的分子分析
- 批准号:
8274768 - 财政年份:2010
- 资助金额:
$ 13.23万 - 项目类别:
Molecular analysis of a kinase essential for replication of Plasmodium falciparum
恶性疟原虫复制所必需的激酶的分子分析
- 批准号:
8037716 - 财政年份:2010
- 资助金额:
$ 13.23万 - 项目类别: